Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634] (Q24793791)

inferred from title

sclerosing cholangitis

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

primary biliary cholangitis

inferred from title

0 references

author

Walter van den Broek

object named as

Walter W van den Broek

3

0 references

Bettina Hansen

object named as

Bettina E Hansen

4

0 references

author name string

Pieter C J ter Borg

1

0 references

Erik van Os

2

0 references

Henk R van Buuren

An Inventory for Measuring Depression

5

0 references

language of work or name

English

0 references

publication date

13 July 2004

0 references

published in

BMC Gastroenterology

0 references

volume

4

0 references

issue

1

0 references

page(s)

13

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481069

The MOS 36-ltem Short-Form Health Survey (SF-36)

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481069

Ursodeoxycholic acid for primary biliary cirrhosis.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481069

Treatment of fibromyalgia with antidepressants: a meta-analysis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481069

Fatigue and radiotherapy: (A) experience in patients undergoing treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481069

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481069

Impact of fatigue on the quality of life of patients with primary biliary cirrhosis.

28 September 2017

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-4-13

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-4-13

Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-4-13

Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-4-13

Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-4-13

Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis

21 January 2018

1 reference

12 December 2020

Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses

1 reference

12 December 2020

Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome

1 reference

12 December 2020

Fatigue in primary biliary cirrhosis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-4-13

1 reference

Dimensions Publication ID

1024188019

0 references

1 reference

1 reference

PubMed publication ID

15251034

1 reference